ISDA and 13 other trade associations have published a paper expressing concern that the EU Benchmarks Regulation (BMR) third-country benchmarks regime transition period should be extended to end-2025. The European Parliament and the Council of the European Union are in final negotiations on a revision of BMR, with the council having supported an extension to end-2025 in its version of the draft text.
The associations believe this extension is urgently needed to prevent putting EU firms being placed at a competitive disadvantage in global markets and to allow policy-makers to conduct a comprehensive review of the current third-country regime under BMR.
Documents (1) for Joint Trade Associations Paper Requesting an Extension of the Third-country Benchmarks Transition Period
Latest
Building Markets, Creating Opportunity
Deep and liquid derivatives markets are fundamental to the development of well-functioning financial markets and healthy economies. They support lending, investment and financial stability, creating the certainty needed for economic growth. But strong derivatives markets do not emerge by chance....
Key Trends in OTC Derivatives Market H2 2025
The latest data from the Bank for International Settlements over-the-counter (OTC) derivatives statistics shows an increase in notional outstanding of OTC derivatives during the second half of 2025 compared to the same period in 2024. Notional outstanding rose across all...
ISDA-SIFMA letter to SEC on Swap Dealer Thresholds
ISDA and SIFMA have submitted a comment letter to the SEC in response to the staff report on the definitions of “security-based swap dealer” and “major security-based swap participant.” The associations recommend maintaining the current de minimis thresholds for both...
ISDA responds to RBI consultation on SA-CCR
On July 1, ISDA responded to the Reserve Bank of India's (RBI) consultation on draft amendment directions on the standardized approach for counterparty credit risk (SA-CCR). ISDA broadly welcomes the RBI's move to SA-CCR and updated capital treatment for exposures...